These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30231392)

  • 41. Metastases of unknown primary site.
    Lembersky BC; Thomas LC
    Med Clin North Am; 1996 Jan; 80(1):153-71. PubMed ID: 8569295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay.
    Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
    Mol Diagn Ther; 2015 Apr; 19(2):91-7. PubMed ID: 25758902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of patients with specific subsets of carcinoma of an unknown primary site.
    Fizazi K
    Ann Oncol; 2006 Sep; 17 Suppl 10():x177-80. PubMed ID: 17018719
    [No Abstract]   [Full Text] [Related]  

  • 44. [Diagnosis and treatment of cancer of unknown origin].
    Vázquez Rivera F; Barón Duarte FJ; López López R
    An Med Interna; 2000 Nov; 17(11):603-8. PubMed ID: 11322036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck.
    de Braud F; al-Sarraf M
    Semin Oncol; 1993 Jun; 20(3):273-8. PubMed ID: 8503023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic work-up and outcome of cervical metastases from an unknown primary.
    Guntinas-Lichius O; Peter Klussmann J; Dinh S; Dinh M; Schmidt M; Semrau R; Mueller RP
    Acta Otolaryngol; 2006 May; 126(5):536-44. PubMed ID: 16698706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
    ESMO.
    Ann Oncol; 2001 Aug; 12(8):1057-8. PubMed ID: 11583184
    [No Abstract]   [Full Text] [Related]  

  • 48. Genomic Profiling of Cancers of Unknown Primary Site--Reply.
    Ross JS; Miller VA; Stephens PJ
    JAMA Oncol; 2015 Jul; 1(4):542-3. PubMed ID: 26181269
    [No Abstract]   [Full Text] [Related]  

  • 49. [Carcinoma unknown primary-clinical practice].
    Onozawa Y
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):799-803. PubMed ID: 25131862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A clinical study of adenocarcinoma of unknown primary site in Hong Kong.
    Teo P; Shiu W; Tsao SY
    Singapore Med J; 1989 Dec; 30(6):571-3. PubMed ID: 2635404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary.
    Tothill RW; Li J; Mileshkin L; Doig K; Siganakis T; Cowin P; Fellowes A; Semple T; Fox S; Byron K; Kowalczyk A; Thomas D; Schofield P; Bowtell DD
    J Pathol; 2013 Dec; 231(4):413-23. PubMed ID: 24037760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
    Cobain EF; Chinnaiyan AM; Kurzrock R; Baker LH
    JAMA Oncol; 2015 Jul; 1(4):542. PubMed ID: 26181268
    [No Abstract]   [Full Text] [Related]  

  • 53. Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
    Varghese AM; Saltz LB
    JAMA Oncol; 2015 Jul; 1(4):541-2. PubMed ID: 26181267
    [No Abstract]   [Full Text] [Related]  

  • 54. Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
    Whang YE; Hayes DN
    JAMA Oncol; 2015 Jul; 1(4):541. PubMed ID: 26181266
    [No Abstract]   [Full Text] [Related]  

  • 55. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
    Worst BC; van Tilburg CM; Balasubramanian GP; Fiesel P; Witt R; Freitag A; Boudalil M; Previti C; Wolf S; Schmidt S; Chotewutmontri S; Bewerunge-Hudler M; Schick M; Schlesner M; Hutter B; Taylor L; Borst T; Sutter C; Bartram CR; Milde T; Pfaff E; Kulozik AE; von Stackelberg A; Meisel R; Borkhardt A; Reinhardt D; Klusmann JH; Fleischhack G; Tippelt S; Dirksen U; Jürgens H; Kramm CM; von Bueren AO; Westermann F; Fischer M; Burkhardt B; Wößmann W; Nathrath M; Bielack SS; Frühwald MC; Fulda S; Klingebiel T; Koscielniak E; Schwab M; Tremmel R; Driever PH; Schulte JH; Brors B; von Deimling A; Lichter P; Eggert A; Capper D; Pfister SM; Jones DT; Witt O
    Eur J Cancer; 2016 Sep; 65():91-101. PubMed ID: 27479119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The big mystery].
    Delorme S; Jäger D
    Radiologe; 2014 Feb; 54(2):106. PubMed ID: 24493101
    [No Abstract]   [Full Text] [Related]  

  • 57. SEOM-GECOD clinical guideline for unknown primary cancer (2021).
    Losa F; Fernández I; Etxaniz O; Giménez A; Gomila P; Iglesias L; Longo F; Nogales E; Sánchez A; Soler G
    Clin Transl Oncol; 2022 Apr; 24(4):681-692. PubMed ID: 35320504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
    Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
    Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treating advanced cancer in an era of increasing cost consciousness.
    Hainsworth JD
    Arch Intern Med; 1995 Oct; 155(19):2035-6. PubMed ID: 7575060
    [No Abstract]   [Full Text] [Related]  

  • 60. Unknown primary tumors.
    Natoli C; Ramazzotti V; Nappi O; Giacomini P; Palmeri S; Salvatore M; Landriscina M; Zilli M; Natali PG; Tinari N; Iacobelli S
    Biochim Biophys Acta; 2011 Aug; 1816(1):13-24. PubMed ID: 21371531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.